Today's Gold and Platinum Prices (June 16)... Gold Prices Decline Amid U.S. Stock Market and Bitcoin Strength
According to the Korea Gold Exchange prices as of June 16, the buying price of pure gold (3.75g) was recorded at 920,000 won, and the selling price at 772,000 w

According to the Korea Gold Exchange prices as of June 16, the buying price of pure gold (3.75g) was recorded at 920,000 won, and the selling price at 772,000 won. The buying price fell by 6,000 won (0.65%) compared to the previous trading day, while the selling price rose by 1,000 won (0.13%).
The selling price of 18K gold was 567,500 won, up 800 won (0.14%) from the previous trading day. The selling price of 14K gold stood at 440,100 won, rising by 600 won (0.14%).
Meanwhile, platinum recorded a buying price of 374,000 won and a selling price of 304,000 won. The buying price declined by 3,000 won (0.8%), and the selling price also dropped by 2,000 won (0.66%), showing weakness.
U.S. Stock Market Shows Strength Centered on Tech Stocks... Gold Price Upward Momentum Expected to Slow
As the U.S. New York stock market shows a strong upward trend, attention is focused on the direction of the gold market, a representative safe-haven asset. With investors' risk appetite returning, some analysis suggests that gold prices may see a temporary slowdown in upward momentum.
On June 16 (Korean time), strength centered on technology stocks was prominent in the U.S. stock market. The Dow Jones Industrial Average rose 0.92%, and the S&P 500 index climbed 1.66%. In particular, the Nasdaq index surged more than 3%, lifting overall market investment sentiment. The Russell 2000 index also closed higher, showing a simultaneous rally in both large-cap and small-to-mid-cap stocks.
Bitcoin Around $66,000... Geopolitical Tension Easing as Background
As of now, based on CoinMarketCap data, Bitcoin is trading around the $66,000 level, showing strength compared to the previous day. The market views the recent easing of geopolitical tensions surrounding the Middle East region as the main background factor.
[※ This article is for reference only in making investment decisions, and the final responsibility for investments lies with the investor.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.

![[Breaking] Aptabio Receives FDA Removal of Clinical Hold for Phase 1 Trial of 'ABF-101'... Dosing Resumes](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/579545/36de0fb87055dd02/variants/hero.webp)